bluebird bio, Inc. (BLUE) Covered Calls
bluebird bio Inc develops, manufactures and markets therapies to deliver genes useful in the treatment of human diseases. Its products portfolio consists of Lenti-D, to treat CCALD;; and LentiGlobin, to treat B-thalassemia and SCD.
There are no covered calls available for bluebird bio, Inc..
Born To Sell's covered call screener gives you full search capabilities so you can find stocks and ETFs that make good covered call candidates.
Want to make money with covered calls? Sign Up For A Free Trial
Extended Business Description
bluebird bio, Inc. is a clinical-stage biotechnology company. The company develops next generation products based on the transformative potential of gene therapy to treat patients with severe genetic and orphan diseases. It has two clinical-stage programs in development for childhood cerebral adrenoleukodystrophy and beta-thalassemia/sickle cell disease and a preclinical oncology program in the chimeric antigen receptor T cells field. bluebird bio was founded by Philippe Leboulch and Ronald C. Dorazio on April 16, 1992 and is headquartered in Cambridge, MA.
| Top 10 Open Interest For Jun 20 Expiration | Top 5 High Yield | |||||
|---|---|---|---|---|---|---|
| 1. | NVDA covered calls | 6. | IWM covered calls | 1. | APP covered calls | |
| 2. | SPY covered calls | 7. | EEM covered calls | 2. | APLD covered calls | |
| 3. | SLV covered calls | 8. | TSLA covered calls | 3. | SFIX covered calls | |
| 4. | QQQ covered calls | 9. | FXI covered calls | 4. | ALT covered calls | |
| 5. | GLD covered calls | 10. | TLT covered calls | 5. | SERV covered calls | |
Want more examples? BLOK Covered Calls | BLV Covered Calls
